Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection.

Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection.

Item
http://www.wikidata.org/entity/Q42249690
B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infection.Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study.Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniaeRespiratory Antiviral Immunity and Immunobiotics: Beneficial Effects on Inflammation-Coagulation Interaction during Influenza Virus Infection.Probiotics in respiratory virus infections.Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505.Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies.Orally Administered Salacia reticulata Extract Reduces H1N1 Influenza Clinical Symptoms in Murine Lung Tissues Putatively Due to Enhanced Natural Killer Cell Activity.Ghost probiotics with a combined regimen: a novel therapeutic approach against the Zika virus, an emerging world threat.Expression of surface-bound nonstructural 1 (NS1) protein of influenza virus A H5N1 on Lactobacillus casei strain C1.High γ-aminobutyric acid production from lactic acid bacteria: Emphasis on Lactobacillus brevis as a functional dairy starter.Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice.Cell-bound exopolysaccharides of Lactobacillus brevis KB290 enhance cytotoxic activity of mouse splenocytes.Cellular fatty acid composition and exopolysaccharide contribute to bile tolerance in Lactobacillus brevis strains isolated from fermented Japanese pickles.
P2860

Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection.

Item
http://www.wikidata.org/entity/Q42249690
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Oral administration of Lactoba ...... ing influenza virus infection.
@en
Oral administration of Lactoba ...... ing influenza virus infection.
@nl
type
label
Oral administration of Lactoba ...... ing influenza virus infection.
@en
Oral administration of Lactoba ...... ing influenza virus infection.
@nl
prefLabel
Oral administration of Lactoba ...... ing influenza virus infection.
@en
Oral administration of Lactoba ...... ing influenza virus infection.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Oral administration of Lactoba ...... ing influenza virus infection.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698